Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00310921 · ClinicalTrials.gov registry record · Phase 2
A Randomized Study of Cervical Priming With Misoprostol Prior to Elective First Trimester Pregnancy Termination
A Phase 2 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT00310921 is a Phase 2 study that has completed, run by Kaiser Permanente. The registered enrollment target is 200 participants.
The verdict
NCT00310921, a Phase 2 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether misoprostol administered prior to elective first trimester pregnancy has an effect on pain and ease of procedure and complications.
Interventions
- DRUG Misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2001-05 |
| Est. Completion | 2006-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00310921
The ClinicalTrials.gov registry entry for NCT00310921 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Misoprostol is the first listed.
NCT00310921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00310921 about?
NCT00310921 is a clinical study titled "A Randomized Study of Cervical Priming With Misoprostol Prior to Elective First Trimester Pregnancy Termination". The purpose of this study is to determine whether misoprostol administered prior to elective first trimester pregnancy has an effect on pain and ease of procedure and complications.
What is the current status of trial NCT00310921?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2001-05. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00310921?
The interventions under investigation include: Misoprostol (DRUG).
Who is sponsoring clinical trial NCT00310921?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.